Zai Lab Ltd logo

Zai Lab Ltd

ZLAB
Healthcare|Biotechnology|China
$20.49
+0.52 (+2.60%)
Tangible Book
$5.25

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 437.58, 561.76, 773.97, 991.35, 1263.55 ], "ebit_estimate": [ -266.12, -204.24, -93.47, 120.9, 208.65 ], "ebitda_estimate": [ -248.6, -194.17, -68.89, null, null ], "net_income_estimate": [ -240.56, -185.97, -77.28, 105.2, 232 ], "per_share_eps_estimate": [ -2.26, -1.79, -0.83, 0.95, 2.1 ], "eps_nri_estimate": [ -2.21, -1.7, -0.72, 0.95, 2.1 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 4.75, 4.42, 4.47, null, null ], "pretax_income_estimate": [ -244.65, -185.96, -53.01, 134.8, 297.5 ], "operating_cash_flow_per_share_estimate": [ -1.65, -1.48, 0.01, null, null ], "roa_estimate": [ -26.18, -22.78, -16.7, null, null ], "roe_estimate": [ -40.37, -39.23, -15.66, null, null ], "gross_margin_estimate": [ 61.27, 63.36, 72, null, null ], "operating_cash_flow_estimate": [ -182.35, -163.53, 1.11, null, null ], "pettm_estimate": [ 0, 0, 0, 21.57, 9.76 ], "long_term_growth_rate_mean": 23.23, "long_term_revenue_growth_rate_mean": "19.84", "future_per_share_eps_estimate_growth": 19.67, "future_eps_nri_estimate_growth": 23.23, "future_revenue_estimate_growth": 19.84, "future_ebit_estimate_growth": 25.61, "future_ebitda_estimate_growth": 30.61, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 23.81, "future_pretax_income_estimate_growth": 32.4, "future_book_value_per_share_estimate_growth": -11.15, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 6.8, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 103.95, 110.77, 118.99, 132, 143.4, 152.2, 165 ], "ebit_estimate": [ -67.17, -61.99, -61.85, -59.1, -54.3, -50.5, -43.1 ], "ebitda_estimate": [ -63.13, -57.16, -57.32, null, null, null, null ], "net_income_estimate": [ -72.83, -59.33, -57.89, -54.5, -49.7, -45.9, -38.6 ], "per_share_eps_estimate": [ -0.57, -0.52, -0.5, -0.49, -0.45, -0.41, -0.35 ], "eps_nri_estimate": [ -0.6, -0.53, -0.53, -0.49, -0.45, -0.41, -0.35 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 5.57, 5.18, 4.82, null, null, null, null ], "pretax_income_estimate": [ -63.79, -59.33, -57.89, -54.5, -49.7, -45.9, -38.6 ], "operating_cash_flow_per_share_estimate": [ -0.49, -0.48, -0.44, null, null, null, null ], "roa_estimate": [ null, null, 2.7, null, null, null, null ], "roe_estimate": [ -36.78, -39.73, -42.76, null, null, null, null ], "gross_margin_estimate": [ 60, 60, 60, null, null, null, null ], "operating_cash_flow_estimate": [ -54.26, -53.16, -48.73, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 23.23, "long_term_revenue_growth_rate_mean": "19.84", "future_per_share_eps_estimate_growth": 19.67, "future_eps_nri_estimate_growth": 23.23, "future_revenue_estimate_growth": 19.84, "future_ebit_estimate_growth": 25.61, "future_ebitda_estimate_growth": 30.61, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": 23.81, "future_pretax_income_estimate_growth": 32.4, "future_book_value_per_share_estimate_growth": -11.15, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": 6.8, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-06-25 04:06:22
2026-06-16 12:00:10
2026-06-16 11:35:21